Identification of phosphodiesterase-9 as a novel target for pulmonary arterial hypertension by using highly selective and orally bioavailable inhibitors
Tian, Y.J., Zhou, Q., Zhang, P., Jiang, M.Y., Zhang, B., Wu, X.N., Zhang, C., Li, Z., Wu, Y., Chen, Z., Luo, H.B.To be published.